Do patients receive any benefit from the addition of perioperative immunotherapy-chemotherapy for solid tumors?

BACKGROUND: Progress in the use of neoadjuvant immunotherapy combined with chemotherapy has become a highlight of cancer research. Our meta-analysis aimed to better elucidate the activity, efficacy and safety of this combination using data obtained from randomized controlled trials (RCTs). METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Quan, Rencui, Li, Zaishang, Zhang, Huaqing, Li, Xueying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
3600
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10589575/
https://www.ncbi.nlm.nih.gov/pubmed/37861545
http://dx.doi.org/10.1097/MD.0000000000035603

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10589575/
https://www.ncbi.nlm.nih.gov/pubmed/37861545
http://dx.doi.org/10.1097/MD.0000000000035603

Ejemplares similares